Detail akcie Inyx online

Business Summary: Inyx, Inc. is a provider of specialty pharmaceutical products and technologies. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.
Financial Summary: BRIEF: For the nine months ended 30 September 2006, Inyx, Inc. revenues increased from $24.1M to $59.6M. Net loss before extraordinary items increased 31% to $22.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling increase from $355K to $4.6M (expense), Depreciation increase from $1.6M to $4.7M (expense).